Clinical Trials · NCT01346098

Islet Autotransplantation in Patients at Very High-risk Pancreatic Anastomosis

CompletedPhase 2Octreotide (Approved)
Phase
Phase 2
Recruitment status
Completed
Sponsor
Ospedale San Raffaele
Enrollment
60
Start date
Jul 2010
Locations
1 site, Italy
Primary endpoint
incidence of complications after pancreatic surgery
View Octreotide compound reference